Last reviewed · How we verify

Placebo oral soft chew

Wake Forest University Health Sciences · FDA-approved active Small molecule

A placebo oral soft chew produces therapeutic effects primarily through the placebo effect, wherein patient expectation and psychological factors trigger physiological responses.

A placebo oral soft chew produces therapeutic effects primarily through the placebo effect, wherein patient expectation and psychological factors trigger physiological responses. Used for Clinical trial control comparator (non-therapeutic use).

At a glance

Generic namePlacebo oral soft chew
SponsorWake Forest University Health Sciences
ModalitySmall molecule
PhaseFDA-approved

Mechanism of action

Placebo formulations activate neural pathways associated with expectation and reward, leading to measurable changes in symptoms and biomarkers independent of pharmacological activity. The soft chew formulation is designed to be administered orally and may enhance the placebo effect through sensory cues and ritualistic administration. This is typically used in clinical research settings to serve as a control comparator for evaluating the true efficacy of active pharmaceutical agents.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: